William C. Lamanna

2.5k total citations · 1 hit paper
17 papers, 1.9k citations indexed

About

William C. Lamanna is a scholar working on Molecular Biology, Cell Biology and Organic Chemistry. According to data from OpenAlex, William C. Lamanna has authored 17 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cell Biology and 7 papers in Organic Chemistry. Recurrent topics in William C. Lamanna's work include Glycosylation and Glycoproteins Research (7 papers), Carbohydrate Chemistry and Synthesis (7 papers) and Lysosomal Storage Disorders Research (7 papers). William C. Lamanna is often cited by papers focused on Glycosylation and Glycoproteins Research (7 papers), Carbohydrate Chemistry and Synthesis (7 papers) and Lysosomal Storage Disorders Research (7 papers). William C. Lamanna collaborates with scholars based in United States, Germany and Austria. William C. Lamanna's co-authors include Jeffrey D. Esko, Sandrine Sarrazin, Thomas Dierks, Marc‐André Frese, Ina Kalus, Roger Lawrence, Catherine L.R. Merry, Martina Balleininger, Geert‐Jan Boons and Kanar Al-Mafraji and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Scientific Reports.

In The Last Decade

William C. Lamanna

17 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Heparan Sulfate Proteoglycans

2011 1.1k citations Sandrine Sarrazin, William C. Lamanna et al. Cold Spring Harbor Perspectives in Biology profile →

Peers

Countries citing papers authored by William C. Lamanna

Since Specialization

Citations

This map shows the geographic impact of William C. Lamanna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William C. Lamanna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William C. Lamanna more than expected).

Fields of papers citing papers by William C. Lamanna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William C. Lamanna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William C. Lamanna. The network helps show where William C. Lamanna may publish in the future.

Co-authorship network of co-authors of William C. Lamanna

This figure shows the co-authorship network connecting the top 25 collaborators of William C. Lamanna. A scholar is included among the top collaborators of William C. Lamanna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William C. Lamanna. William C. Lamanna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Impaired mitophagy in Sanfilippo a mice causes hypertriglyceridemia and brown adipose tissue activation 2022 ·Journal of Biological Chemistry ·(unknown), William C. Lamanna, Chrissa A. Dwyer, Daniel R. Sandoval, Ariane Pessentheiner, (unknown), Stéphane Sarrazin, Jon C. Gonzales, Shih‐hsin Kan, Alexander Y. Andreyev, (unknown), Bryan E. Thacker, Charles A. Glass, Patricia Dickson, Raymond Wang, Scott B. Selleck, Jeffrey D. Esko, Philip L.S.M. Gordts	3
2	The structure-function relationship of disulfide bonds in etanercept 2017 ·Scientific Reports ·William C. Lamanna, (unknown), (unknown), Michael Fuchs, Fabian Higel, Cornelius Fritsch, (unknown), Andreas Seidl, (unknown), Martin Schiestl, Johann Holzmann	27
3	The in-use stability of the rituximab biosimilar Rixathon®/Riximyo® upon preparation for intravenous infusion 2017 ·Journal of Oncology Pharmacy Practice ·William C. Lamanna, Katharina Heller, (unknown), (unknown), (unknown), Cornelius Fritsch, Martin Schiestl	21
4	Arylsulfatase K is the Lysosomal 2-Sulfoglucuronate Sulfatase 2017 ·ACS Chemical Biology ·(unknown), Roger Lawrence, (unknown), Bhahwal Ali Shah, Kanar Al-Mafraji, William C. Lamanna, Torben Lübke, Thomas Dierks, Geert‐Jan Boons, Jeffrey D. Esko	11
5	Maintaining consistent quality and clinical performance of biopharmaceuticals 2017 ·Expert Opinion on Biological Therapy ·William C. Lamanna, Johann Holzmann, Hillel P. Cohen, (unknown), (unknown), Thomas Stangler, Andreas Seidl, Martin Schiestl	44
6	Identification of Low-Level Product-Related Variants in Filgrastim Products Presently Available in Highly Regulated Markets 2016 ·BioDrugs ·(unknown), William C. Lamanna, Martin Hartinger, Andreas Seidl, (unknown), Johann Holzmann	7
7	Intra-articular enzyme replacement therapy with rhIDUA is safe, well-tolerated, and reduces articular GAG storage in the canine model of mucopolysaccharidosis type I 2014 ·Molecular Genetics and Metabolism ·Raymond Wang, (unknown), Michael F. McEntee, Shih‐hsin Kan, Calogera M. Simonaro, William C. Lamanna, Roger Lawrence, N. Matthew Ellinwood, (unknown), Steven Q. Le, Patricia Dickson, Jeffrey D. Esko	14
8	Arylsulfatase G inactivation causes loss of heparan sulfate 3- O -sulfatase activity and mucopolysaccharidosis in mice 2012 ·Proceedings of the National Academy of Sciences ·(unknown), William C. Lamanna, Roger Lawrence, Markus Daμμe, Stijn Stroobants, (unknown), Ina Kalus, Marc‐André Frese, Torben Lübke, Renate Lüllmann‐Rauch, Rudi D’Hooge, Jeffrey D. Esko, Thomas Dierks	55
9	Disease-specific non–reducing end carbohydrate biomarkers for mucopolysaccharidoses 2012 ·Nature Chemical Biology ·Roger Lawrence, Jillian R. Brown, Kanar Al-Mafraji, William C. Lamanna, (unknown), Geert‐Jan Boons, Jeffrey D. Esko, Brett E. Crawford	116
10	A Genetic Model of Substrate Reduction Therapy for Mucopolysaccharidosis 2012 ·Journal of Biological Chemistry ·William C. Lamanna, Roger Lawrence, Stéphane Sarrazin, (unknown), Philip L.S.M. Gordts, Kelley W. Moremen, Jeffrey D. Esko	22
11	Diagnosis and Monitoring of Mucopolysaccharidoses Using Disease-Specific Non-Reducing End Carbohydrate Biomarkers 2012 ·Molecular Genetics and Metabolism ·Jillian R. Brown, Roger Lawrence, Kanar Al-Mafraji, William C. Lamanna, (unknown), Geert‐Jan Boons, Jeffrey D. Esko, Brett E. Crawford	1
12	Heparan Sulfate Proteoglycans breakdown → 2011 ·Cold Spring Harbor Perspectives in Biology ·Sandrine Sarrazin, William C. Lamanna, Jeffrey D. Esko	1146
13	Secondary Storage of Dermatan Sulfate in Sanfilippo Disease 2010 ·Journal of Biological Chemistry ·William C. Lamanna, Roger Lawrence, Stéphane Sarrazin, Jeffrey D. Esko	45
14	Characterization of the Human Sulfatase Sulf1 and Its High Affinity Heparin/Heparan Sulfate Interaction Domain 2009 ·Journal of Biological Chemistry ·Marc‐André Frese, (unknown), (unknown), William C. Lamanna, Thomas Dierks	65
15	Sulf Loss Influences N-, 2-O-, and 6-O-Sulfation of Multiple Heparan Sulfate Proteoglycans and Modulates Fibroblast Growth Factor Signaling 2008 ·Journal of Biological Chemistry ·William C. Lamanna, Marc‐André Frese, Martina Balleininger, Thomas Dierks	117
16	The heparanome—The enigma of encoding and decoding heparan sulfate sulfation 2007 ·Journal of Biotechnology ·William C. Lamanna, Ina Kalus, (unknown), (unknown), Catherine L.R. Merry, Thomas Dierks	151
17	Heparan sulfate 6-O-endosulfatases: discrete in vivo activities and functional co-operativity 2006 ·Biochemical Journal ·William C. Lamanna, (unknown), (unknown), Ina Kalus, Gerdy ten Dam, Toin H. Van Kuppevelt, John T. Gallagher, Kurt Von Figura, Thomas Dierks, Catherine L.R. Merry	103

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact